Trk and their NT ligands have been also found in malignant B cell lines notably multiple myeloma and NHL cell lines [22], [23] but involvement of NTs in the pathogeny of B cell tumors, and notably in DLBCL, needs to be elucidated. This evidence concerns the gene NTRK1 and non-Hodgkin lymphoma.